MED Medifast PE ratio, current and historical analysis
- Stocks
- Consumer Cyclical
- NYSE: MED
- PE Ratio
The current PE ratio of MED cannot be calculated, as the latest EPS of -$0.65 is negative. The last recorded PE ratio for Medifast was 92.74 in December 2024.
MED PE ratio history
The average historical PE ratio of Medifast for the last ten years is 22.3. Analyzing the last ten years, MED's PE ratio reached its highest point in the Dec 2024 quarter at 92.74, when the price was $17.62 and the EPS was $0.19. The lowest point was recorded in the Mar 2024 quarter, when it reached 6.17 with a price of $38.32 and an EPS of $6.21.
Medifast PE ratio by year
Maximum annual increase: 1,160.05% in 2024
Maximum annual decrease: -50.34% in 2011
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 92.74 | 1,160.05% | $17.62 | $0.19 |
| 2023 | 7.36 | -18.22% | $67.22 | $9.13 |
| 2022 | 9 | -39.8% | $115.35 | $12.82 |
| 2021 | 14.95 | -33.44% | $209.43 | $14.01 |
| 2020 | 22.46 | 35.71% | $196.34 | $8.74 |
| 2019 | 16.55 | -38.18% | $109.58 | $6.62 |
| 2018 | 26.77 | -11.03% | $125.02 | $4.67 |
| 2017 | 30.09 | 9.14% | $69.81 | $2.32 |
| 2016 | 27.57 | 52.49% | $41.63 | $1.51 |
| 2015 | 18.08 | -43.96% | $30.38 | $1.68 |
| 2014 | 32.26 | 114.78% | $33.55 | $1.04 |
| 2013 | 15.02 | -33.98% | $26.13 | $1.74 |
| 2012 | 22.75 | 120.45% | $26.39 | $1.16 |
| 2011 | 10.32 | -50.34% | $13.72 | $1.33 |
| 2010 | 20.78 | -42.91% | $28.88 | $1.39 |
Medifast PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | N/A | N/A | $13.48 | -$0.65 |
| Dec 2024 | 92.74 | 219.79% | $17.62 | $0.19 |
| Sep 2024 | 29 | 256.27% | $19.14 | $0.66 |
| Jun 2024 | 8.14 | 31.93% | $21.82 | $2.68 |
| Mar 2024 | 6.17 | -16.17% | $38.32 | $6.21 |
| Dec 2023 | 7.36 | 8.39% | $67.22 | $9.13 |
| Sep 2023 | 6.79 | -10.07% | $74.85 | $11.03 |
| Jun 2023 | 7.55 | -6.33% | $92.16 | $12.21 |
| Mar 2023 | 8.06 | -10.44% | $103.67 | $12.87 |
| Dec 2022 | 9 | 10.43% | $115.35 | $12.82 |
| Sep 2022 | 8.15 | -38.63% | $108.36 | $13.3 |
| Jun 2022 | 13.28 | 10.02% | $180.51 | $13.59 |
| Mar 2022 | 12.07 | -19.26% | $170.78 | $14.15 |
| Dec 2021 | 14.95 | 4.47% | $209.43 | $14.01 |
| Sep 2021 | 14.31 | -35.28% | $192.64 | $13.46 |
MED Price vs fair value
MED average PE ratio chart
MED PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| WTW Willis Towers Watson Plc | N/A | $30.54B |
| ABEO Abeona Therapeutics Inc | N/A | $278.1M |
| MED Medifast Inc | N/A | $142.88M |
Frequently asked questions
What is Medifast's PE ratio?
The current price to earnings ratio of MED cannot be determined, as its EPS of -$0.65 is negative.
What is the 3-year average PE ratio for Medifast (MED)?
Over the last 3 years, the average PE ratio for MED stock is 17.84.
What is the 5-year average PE ratio for Medifast (MED)?
Over the last 5 years, the average PE ratio for MED stock is 18.09.
What is the highest PE ratio for MED?
Over the last ten years, the quarterly PE ratio reached its highest level at 92.74 in the Dec 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.